PMV Pharmaceuticals, Inc. (PMVP) Misses Q2 EPS by 2c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q2 EPS of ($0.41), $0.02 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• Lightspeed POS Inc. (LSPD)Assumed at Equalweight at Morgan Stanley
• Kodiak Sciences Inc. (KOD) PT Lowered to $112 at Jefferies